Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Other Operating Expenses (2016 - 2024)

Historic Other Operating Expenses for Theravance Biopharma (TBPH) over the last 8 years, with Q3 2024 value amounting to $1.6 million.

  • Theravance Biopharma's Other Operating Expenses changed N/A to $1.6 million in Q3 2024 from the same period last year, while for Jun 2025 it was $1.6 million, marking a year-over-year decrease of 4706.88%. This contributed to the annual value of $4.5 million for FY2024, which is N/A changed from last year.
  • Per Theravance Biopharma's latest filing, its Other Operating Expenses stood at $1.6 million for Q3 2024.
  • Over the past 5 years, Theravance Biopharma's Other Operating Expenses peaked at $3.8 million during Q2 2022, and registered a low of -$37.5 million during Q3 2022.
  • For the 3-year period, Theravance Biopharma's Other Operating Expenses averaged around -$4.0 million, with its median value being $1.3 million (2022).